From September 29, 2014 to December 31, 2014, the company has repurchased 40,040,748 shares, representing 0.64% for $1,198.82 million. With this, the company has completed the repurchase of 311,841,966 shares, representing 4.86% for $9,483.28 million under the buyback announced on June 27, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.05 USD | +1.26% |
|
+0.25% | -2.57% |
05/07 | Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code | MT |
05/07 | UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.57% | 159B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Tranche Update on Pfizer Inc.'s Equity Buyback Plan announced on June 27, 2013.